1h Free Analyst Time
The global radiopharmaceuticals market is forecasted to grow by USD 7.75 billion during 2025-2030, accelerating at a CAGR of 12.3% during the forecast period. The report on the global radiopharmaceuticals market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising incidence of neurological disorders, growing cancer cases and rising investment in oncology market, minimal side effects of radiopharmaceuticals.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The global radiopharmaceuticals market is segmented as below:
By Source
- Cyclotrons
- Nuclear reactors
By End-User
- Diagnostics
- Therapeutics
By Application
- Oncology
- Cardiology
- Neurology
By Region
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Russia
- The Netherlands
- Spain
- Asia
- Rest of World (RoW)
The report on the global radiopharmaceuticals market covers the following areas:
- Global radiopharmaceuticals market sizing
- Global radiopharmaceuticals market forecast
- Global radiopharmaceuticals market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Source
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Chart on Overview on criticality of inputs and factors of differentiation
- Chart on Overview on factors of disruption
- Chart on Impact of drivers and challenges in 2025 and 2030
3 Market Landscape
3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
- Chart on Market characteristics analysis
- Chart on Value chain analysis
4 Market Sizing
4.1 Market definition
4.4 Market outlook: Forecast for 2025-2030
- Data Table on Offerings of companies included in the market definition
- Market segments
4.4 Market outlook: Forecast for 2025-2030
- Chart on Global - Market size and forecast 2025-2030 ($ million)
- Data Table on Global - Market size and forecast 2025-2030 ($ million)
- Chart on Global Market: Year-over-year growth 2025-2030 (%)
- Data Table on Global Market: Year-over-year growth 2025-2030 (%)
5 Historic Market Size
5.1 Global Radiopharmaceuticals Market 2020 - 2024
- Historic Market Size - Data Table on Global Radiopharmaceuticals Market 2020 - 2024 ($ million)
- Historic Market Size - Source Segment 2020 - 2024 ($ million)
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
- Historic Market Size - Application Segment 2020 - 2024 ($ million)
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
6.1 AI Impact on Global Radiopharmaceuticals Market
7 Five Forces Analysis
7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- Threat of new entrants - Impact of key factors in 2025 and 2030
- Threat of substitutes - Impact of key factors in 2025 and 2030
- Threat of rivalry - Impact of key factors in 2025 and 2030
- Chart on Market condition - Five forces 2025 and 2030
8 Market Segmentation by Source
8.1 Market segments
- Chart on Source - Market share 2025-2030 (%)
- Data Table on Source - Market share 2025-2030 (%)
- Chart on Comparison by Source
- Data Table on Comparison by Source
- Chart on Cyclotrons - Market size and forecast 2025-2030 ($ million)
- Data Table on Cyclotrons - Market size and forecast 2025-2030 ($ million)
- Chart on Cyclotrons - Year-over-year growth 2025-2030 (%)
- Data Table on Cyclotrons - Year-over-year growth 2025-2030 (%)
- Chart on Nuclear reactors - Market size and forecast 2025-2030 ($ million)
- Data Table on Nuclear reactors - Market size and forecast 2025-2030 ($ million)
- Chart on Nuclear reactors - Year-over-year growth 2025-2030 (%)
- Data Table on Nuclear reactors - Year-over-year growth 2025-2030 (%)
- Market opportunity by Source ($ million)
- Data Table on Market opportunity by Source ($ million)
9 Market Segmentation by End-user
9.1 Market segments
- Chart on End-user - Market share 2025-2030 (%)
- Data Table on End-user - Market share 2025-2030 (%)
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
- Chart on Diagnostics - Market size and forecast 2025-2030 ($ million)
- Data Table on Diagnostics - Market size and forecast 2025-2030 ($ million)
- Chart on Diagnostics - Year-over-year growth 2025-2030 (%)
- Data Table on Diagnostics - Year-over-year growth 2025-2030 (%)
- Chart on Therapeutics - Market size and forecast 2025-2030 ($ million)
- Data Table on Therapeutics - Market size and forecast 2025-2030 ($ million)
- Chart on Therapeutics - Year-over-year growth 2025-2030 (%)
- Data Table on Therapeutics - Year-over-year growth 2025-2030 (%)
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)
10 Market Segmentation by Application
10.1 Market segments
- Chart on Application - Market share 2025-2030 (%)
- Data Table on Application - Market share 2025-2030 (%)
- Chart on Comparison by Application
- Data Table on Comparison by Application
- Chart on Oncology - Market size and forecast 2025-2030 ($ million)
- Data Table on Oncology - Market size and forecast 2025-2030 ($ million)
- Chart on Oncology - Year-over-year growth 2025-2030 (%)
- Data Table on Oncology - Year-over-year growth 2025-2030 (%)
- Chart on Cardiology - Market size and forecast 2025-2030 ($ million)
- Data Table on Cardiology - Market size and forecast 2025-2030 ($ million)
- Chart on Cardiology - Year-over-year growth 2025-2030 (%)
- Data Table on Cardiology - Year-over-year growth 2025-2030 (%)
- Chart on Neurology - Market size and forecast 2025-2030 ($ million)
- Data Table on Neurology - Market size and forecast 2025-2030 ($ million)
- Chart on Neurology - Year-over-year growth 2025-2030 (%)
- Data Table on Neurology - Year-over-year growth 2025-2030 (%)
- Market opportunity by Application ($ million)
- Data Table on Market opportunity by Application ($ million)
11 Customer Landscape
11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
- Chart on Market share by geography 2025-2030 (%)
- Data Table on Market share by geography 2025-2030 (%)
- Chart on Geographic comparison
- Data Table on Geographic comparison
- Chart on North America - Market size and forecast 2025-2030 ($ million)
- Data Table on North America - Market size and forecast 2025-2030 ($ million)
- Chart on North America - Year-over-year growth 2025-2030 (%)
- Data Table on North America - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- Chart on US - Market size and forecast 2025-2030 ($ million)
- Data Table on US - Market size and forecast 2025-2030 ($ million)
- Chart on US - Year-over-year growth 2025-2030 (%)
- Data Table on US - Year-over-year growth 2025-2030 (%)
- Chart on Canada - Market size and forecast 2025-2030 ($ million)
- Data Table on Canada - Market size and forecast 2025-2030 ($ million)
- Chart on Canada - Year-over-year growth 2025-2030 (%)
- Data Table on Canada - Year-over-year growth 2025-2030 (%)
- Chart on Mexico - Market size and forecast 2025-2030 ($ million)
- Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
- Chart on Mexico - Year-over-year growth 2025-2030 (%)
- Data Table on Mexico - Year-over-year growth 2025-2030 (%)
- Chart on Europe - Market size and forecast 2025-2030 ($ million)
- Data Table on Europe - Market size and forecast 2025-2030 ($ million)
- Chart on Europe - Year-over-year growth 2025-2030 (%)
- Data Table on Europe - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- Chart on Germany - Market size and forecast 2025-2030 ($ million)
- Data Table on Germany - Market size and forecast 2025-2030 ($ million)
- Chart on Germany - Year-over-year growth 2025-2030 (%)
- Data Table on Germany - Year-over-year growth 2025-2030 (%)
- Chart on UK - Market size and forecast 2025-2030 ($ million)
- Data Table on UK - Market size and forecast 2025-2030 ($ million)
- Chart on UK - Year-over-year growth 2025-2030 (%)
- Data Table on UK - Year-over-year growth 2025-2030 (%)
- Chart on France - Market size and forecast 2025-2030 ($ million)
- Data Table on France - Market size and forecast 2025-2030 ($ million)
- Chart on France - Year-over-year growth 2025-2030 (%)
- Data Table on France - Year-over-year growth 2025-2030 (%)
- Chart on Italy - Market size and forecast 2025-2030 ($ million)
- Data Table on Italy - Market size and forecast 2025-2030 ($ million)
- Chart on Italy - Year-over-year growth 2025-2030 (%)
- Data Table on Italy - Year-over-year growth 2025-2030 (%)
- Chart on Russia - Market size and forecast 2025-2030 ($ million)
- Data Table on Russia - Market size and forecast 2025-2030 ($ million)
- Chart on Russia - Year-over-year growth 2025-2030 (%)
- Data Table on Russia - Year-over-year growth 2025-2030 (%)
- Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
- Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
- Chart on Spain - Market size and forecast 2025-2030 ($ million)
- Data Table on Spain - Market size and forecast 2025-2030 ($ million)
- Chart on Spain - Year-over-year growth 2025-2030 (%)
- Data Table on Spain - Year-over-year growth 2025-2030 (%)
- Chart on Asia - Market size and forecast 2025-2030 ($ million)
- Data Table on Asia - Market size and forecast 2025-2030 ($ million)
- Chart on Asia - Year-over-year growth 2025-2030 (%)
- Data Table on Asia - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Asia
- Data Table on Regional Comparison - Asia
- Chart on China - Market size and forecast 2025-2030 ($ million)
- Data Table on China - Market size and forecast 2025-2030 ($ million)
- Chart on China - Year-over-year growth 2025-2030 (%)
- Data Table on China - Year-over-year growth 2025-2030 (%)
- Chart on Japan - Market size and forecast 2025-2030 ($ million)
- Data Table on Japan - Market size and forecast 2025-2030 ($ million)
- Chart on Japan - Year-over-year growth 2025-2030 (%)
- Data Table on Japan - Year-over-year growth 2025-2030 (%)
- Chart on India - Market size and forecast 2025-2030 ($ million)
- Data Table on India - Market size and forecast 2025-2030 ($ million)
- Chart on India - Year-over-year growth 2025-2030 (%)
- Data Table on India - Year-over-year growth 2025-2030 (%)
- Chart on South Korea - Market size and forecast 2025-2030 ($ million)
- Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
- Chart on South Korea - Year-over-year growth 2025-2030 (%)
- Data Table on South Korea - Year-over-year growth 2025-2030 (%)
- Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
- Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
- Chart on Indonesia - Year-over-year growth 2025-2030 (%)
- Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
- Chart on Singapore - Market size and forecast 2025-2030 ($ million)
- Data Table on Singapore - Market size and forecast 2025-2030 ($ million)
- Chart on Singapore - Year-over-year growth 2025-2030 (%)
- Data Table on Singapore - Year-over-year growth 2025-2030 (%)
- Chart on Thailand - Market size and forecast 2025-2030 ($ million)
- Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
- Chart on Thailand - Year-over-year growth 2025-2030 (%)
- Data Table on Thailand - Year-over-year growth 2025-2030 (%)
- Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Rest of World (ROW)
- Data Table on Regional Comparison - Rest of World (ROW)
- Chart on Australia - Market size and forecast 2025-2030 ($ million)
- Data Table on Australia - Market size and forecast 2025-2030 ($ million)
- Chart on Australia - Year-over-year growth 2025-2030 (%)
- Data Table on Australia - Year-over-year growth 2025-2030 (%)
- Chart on Brazil - Market size and forecast 2025-2030 ($ million)
- Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
- Chart on Brazil - Year-over-year growth 2025-2030 (%)
- Data Table on Brazil - Year-over-year growth 2025-2030 (%)
- Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Chart on South Africa - Market size and forecast 2025-2030 ($ million)
- Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
- Chart on South Africa - Year-over-year growth 2025-2030 (%)
- Data Table on South Africa - Year-over-year growth 2025-2030 (%)
- Chart on UAE - Market size and forecast 2025-2030 ($ million)
- Data Table on UAE - Market size and forecast 2025-2030 ($ million)
- Chart on UAE - Year-over-year growth 2025-2030 (%)
- Data Table on UAE - Year-over-year growth 2025-2030 (%)
- Chart on Turkey - Market size and forecast 2025-2030 ($ million)
- Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
- Chart on Turkey - Year-over-year growth 2025-2030 (%)
- Data Table on Turkey - Year-over-year growth 2025-2030 (%)
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
13.1 Market drivers
- Rising incidence of neurological disorders
- Growing cancer cases and rising investment in oncology market
- Minimal side effects of radiopharmaceuticals
- Preparation and dispensing problems associated with radiopharmaceuticals
- Shortage of radioisotopes
- Regulatory hurdles regarding preparation of radiopharmaceuticals
- Impact of drivers and challenges in 2025 and 2030
- Production of cyclotron-based radiopharmaceuticals
- Discovery and development of new radiopharmaceuticals
- Improvement in healthcare infrastructure in emerging economies
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- Overview on factors of disruption
- Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
- Companies covered
- Company ranking index
- Matrix on companies position and classification
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key news
- Bayer AG - Key offerings
- Bayer AG - Segment focus
- SWOT
- Bracco S.p.A. - Overview
- Bracco S.p.A. - Product / Service
- Bracco S.p.A. - Key offerings
- SWOT
- Cardinal Health Inc. - Overview
- Cardinal Health Inc. - Business segments
- Cardinal Health Inc. - Key news
- Cardinal Health Inc. - Key offerings
- Cardinal Health Inc. - Segment focus
- SWOT
- Curium Pharma - Overview
- Curium Pharma - Product / Service
- Curium Pharma - Key offerings
- SWOT
- Eckert and Ziegler AG - Overview
- Eckert and Ziegler AG - Business segments
- Eckert and Ziegler AG - Key news
- Eckert and Ziegler AG - Key offerings
- Eckert and Ziegler AG - Segment focus
- SWOT
- GE Healthcare Technologies - Overview
- GE Healthcare Technologies - Business segments
- GE Healthcare Technologies - Key news
- GE Healthcare Technologies - Key offerings
- GE Healthcare Technologies - Segment focus
- SWOT
- IBA Radiopharma Solutions - Overview
- IBA Radiopharma Solutions - Business segments
- IBA Radiopharma Solutions - Key news
- IBA Radiopharma Solutions - Key offerings
- IBA Radiopharma Solutions - Segment focus
- SWOT
- Jubilant Pharma Ltd. - Overview
- Jubilant Pharma Ltd. - Product / Service
- Jubilant Pharma Ltd. - Key offerings
- SWOT
- Lantheus - Overview
- Lantheus - Business segments
- Lantheus - Key offerings
- Lantheus - Segment focus
- SWOT
- NorthStar Medical Radioisotopes - Overview
- NorthStar Medical Radioisotopes - Product / Service
- NorthStar Medical Radioisotopes - Key offerings
- SWOT
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
- NTP Radioisotopes SOC Ltd. - Overview
- NTP Radioisotopes SOC Ltd. - Product / Service
- NTP Radioisotopes SOC Ltd. - Key offerings
- SWOT
- PharmaLogic Holdings Corp. - Overview
- PharmaLogic Holdings Corp. - Product / Service
- PharmaLogic Holdings Corp. - Key offerings
- SWOT
- Siemens Healthineers AG - Overview
- Siemens Healthineers AG - Business segments
- Siemens Healthineers AG - Key news
- Siemens Healthineers AG - Key offerings
- Siemens Healthineers AG - Segment focus
- SWOT
- Sinotau Pharmaceuticals - Overview
- Sinotau Pharmaceuticals - Product / Service
- Sinotau Pharmaceuticals - Key offerings
- SWOT
16 Appendix
16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- Inclusions checklist
- Exclusions checklist
- Currency conversion rates for US$
- Research methodology
- Information sources
- Data validation
- Validation techniques employed for market sizing
- Data synthesis
- 360 degree market analysis
- List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Source
Exhibit 6: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 7: Executive Summary - Chart on Market Segmentation by Application
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 22: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Historic Market Size - Data Table on Global Radiopharmaceuticals Market 2020 - 2024 ($ million)
Exhibit 26: Historic Market Size - Source Segment 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - End-user Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - Application Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 31: Five forces analysis - Comparison between 2025 and 2030
Exhibit 32: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 34: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 35: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 37: Chart on Market condition - Five forces 2025 and 2030
Exhibit 38: Chart on Source - Market share 2025-2030 (%)
Exhibit 39: Data Table on Source - Market share 2025-2030 (%)
Exhibit 40: Chart on Comparison by Source
Exhibit 41: Data Table on Comparison by Source
Exhibit 42: Chart on Cyclotrons - Market size and forecast 2025-2030 ($ million)
Exhibit 43: Data Table on Cyclotrons - Market size and forecast 2025-2030 ($ million)
Exhibit 44: Chart on Cyclotrons - Year-over-year growth 2025-2030 (%)
Exhibit 45: Data Table on Cyclotrons - Year-over-year growth 2025-2030 (%)
Exhibit 46: Chart on Nuclear reactors - Market size and forecast 2025-2030 ($ million)
Exhibit 47: Data Table on Nuclear reactors - Market size and forecast 2025-2030 ($ million)
Exhibit 48: Chart on Nuclear reactors - Year-over-year growth 2025-2030 (%)
Exhibit 49: Data Table on Nuclear reactors - Year-over-year growth 2025-2030 (%)
Exhibit 50: Market opportunity by Source ($ million)
Exhibit 51: Data Table on Market opportunity by Source ($ million)
Exhibit 52: Chart on End-user - Market share 2025-2030 (%)
Exhibit 53: Data Table on End-user - Market share 2025-2030 (%)
Exhibit 54: Chart on Comparison by End-user
Exhibit 55: Data Table on Comparison by End-user
Exhibit 56: Chart on Diagnostics - Market size and forecast 2025-2030 ($ million)
Exhibit 57: Data Table on Diagnostics - Market size and forecast 2025-2030 ($ million)
Exhibit 58: Chart on Diagnostics - Year-over-year growth 2025-2030 (%)
Exhibit 59: Data Table on Diagnostics - Year-over-year growth 2025-2030 (%)
Exhibit 60: Chart on Therapeutics - Market size and forecast 2025-2030 ($ million)
Exhibit 61: Data Table on Therapeutics - Market size and forecast 2025-2030 ($ million)
Exhibit 62: Chart on Therapeutics - Year-over-year growth 2025-2030 (%)
Exhibit 63: Data Table on Therapeutics - Year-over-year growth 2025-2030 (%)
Exhibit 64: Market opportunity by End-user ($ million)
Exhibit 65: Data Table on Market opportunity by End-user ($ million)
Exhibit 66: Chart on Application - Market share 2025-2030 (%)
Exhibit 67: Data Table on Application - Market share 2025-2030 (%)
Exhibit 68: Chart on Comparison by Application
Exhibit 69: Data Table on Comparison by Application
Exhibit 70: Chart on Oncology - Market size and forecast 2025-2030 ($ million)
Exhibit 71: Data Table on Oncology - Market size and forecast 2025-2030 ($ million)
Exhibit 72: Chart on Oncology - Year-over-year growth 2025-2030 (%)
Exhibit 73: Data Table on Oncology - Year-over-year growth 2025-2030 (%)
Exhibit 74: Chart on Cardiology - Market size and forecast 2025-2030 ($ million)
Exhibit 75: Data Table on Cardiology - Market size and forecast 2025-2030 ($ million)
Exhibit 76: Chart on Cardiology - Year-over-year growth 2025-2030 (%)
Exhibit 77: Data Table on Cardiology - Year-over-year growth 2025-2030 (%)
Exhibit 78: Chart on Neurology - Market size and forecast 2025-2030 ($ million)
Exhibit 79: Data Table on Neurology - Market size and forecast 2025-2030 ($ million)
Exhibit 80: Chart on Neurology - Year-over-year growth 2025-2030 (%)
Exhibit 81: Data Table on Neurology - Year-over-year growth 2025-2030 (%)
Exhibit 82: Market opportunity by Application ($ million)
Exhibit 83: Data Table on Market opportunity by Application ($ million)
Exhibit 84: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 85: Chart on Market share by geography 2025-2030 (%)
Exhibit 86: Data Table on Market share by geography 2025-2030 (%)
Exhibit 87: Chart on Geographic comparison
Exhibit 88: Data Table on Geographic comparison
Exhibit 89: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 90: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 91: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 92: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 93: Chart on Regional Comparison - North America
Exhibit 94: Data Table on Regional Comparison - North America
Exhibit 95: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 96: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 97: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 98: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 99: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 100: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 101: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 102: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 103: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 104: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 105: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 106: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 107: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 108: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 109: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 110: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 111: Chart on Regional Comparison - Europe
Exhibit 112: Data Table on Regional Comparison - Europe
Exhibit 113: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 114: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 115: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 116: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 117: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 118: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 119: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 120: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 121: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 122: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 123: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 124: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 125: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 126: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 127: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 128: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 129: Chart on Russia - Market size and forecast 2025-2030 ($ million)
Exhibit 130: Data Table on Russia - Market size and forecast 2025-2030 ($ million)
Exhibit 131: Chart on Russia - Year-over-year growth 2025-2030 (%)
Exhibit 132: Data Table on Russia - Year-over-year growth 2025-2030 (%)
Exhibit 133: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 134: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 135: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 136: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 137: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 138: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 139: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 142: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 143: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 144: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 145: Chart on Regional Comparison - Asia
Exhibit 146: Data Table on Regional Comparison - Asia
Exhibit 147: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 148: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 149: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 150: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 151: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 152: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 153: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 154: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 155: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 156: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 157: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 158: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 159: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 160: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 161: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 162: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 163: Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 164: Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 165: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 166: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 167: Chart on Singapore - Market size and forecast 2025-2030 ($ million)
Exhibit 168: Data Table on Singapore - Market size and forecast 2025-2030 ($ million)
Exhibit 169: Chart on Singapore - Year-over-year growth 2025-2030 (%)
Exhibit 170: Data Table on Singapore - Year-over-year growth 2025-2030 (%)
Exhibit 171: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 172: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 173: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 174: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 175: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 176: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 177: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 178: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 179: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 180: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 181: Chart on Australia - Market size and forecast 2025-2030 ($ million)
Exhibit 182: Data Table on Australia - Market size and forecast 2025-2030 ($ million)
Exhibit 183: Chart on Australia - Year-over-year growth 2025-2030 (%)
Exhibit 184: Data Table on Australia - Year-over-year growth 2025-2030 (%)
Exhibit 185: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 186: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 187: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 188: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 189: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 190: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 191: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 192: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 193: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 194: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 195: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 196: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 197: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 198: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 199: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 200: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 201: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 202: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 203: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 204: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 205: Market opportunity by geography ($ million)
Exhibit 206: Data Tables on Market opportunity by geography ($ million)
Exhibit 207: Impact of drivers and challenges in 2025 and 2030
Exhibit 208: Overview on criticality of inputs and factors of differentiation
Exhibit 209: Overview on factors of disruption
Exhibit 210: Impact of key risks on business
Exhibit 211: Companies covered
Exhibit 212: Company ranking index
Exhibit 213: Matrix on companies position and classification
Exhibit 214: Bayer AG - Overview
Exhibit 215: Bayer AG - Business segments
Exhibit 216: Bayer AG - Key news
Exhibit 217: Bayer AG - Key offerings
Exhibit 218: Bayer AG - Segment focus
Exhibit 219: SWOT
Exhibit 220: Bracco S.p.A. - Overview
Exhibit 221: Bracco S.p.A. - Product / Service
Exhibit 222: Bracco S.p.A. - Key offerings
Exhibit 223: SWOT
Exhibit 224: Cardinal Health Inc. - Overview
Exhibit 225: Cardinal Health Inc. - Business segments
Exhibit 226: Cardinal Health Inc. - Key news
Exhibit 227: Cardinal Health Inc. - Key offerings
Exhibit 228: Cardinal Health Inc. - Segment focus
Exhibit 229: SWOT
Exhibit 230: Curium Pharma - Overview
Exhibit 231: Curium Pharma - Product / Service
Exhibit 232: Curium Pharma - Key offerings
Exhibit 233: SWOT
Exhibit 234: Eckert and Ziegler AG - Overview
Exhibit 235: Eckert and Ziegler AG - Business segments
Exhibit 236: Eckert and Ziegler AG - Key news
Exhibit 237: Eckert and Ziegler AG - Key offerings
Exhibit 238: Eckert and Ziegler AG - Segment focus
Exhibit 239: SWOT
Exhibit 240: GE Healthcare Technologies - Overview
Exhibit 241: GE Healthcare Technologies - Business segments
Exhibit 242: GE Healthcare Technologies - Key news
Exhibit 243: GE Healthcare Technologies - Key offerings
Exhibit 244: GE Healthcare Technologies - Segment focus
Exhibit 245: SWOT
Exhibit 246: IBA Radiopharma Solutions - Overview
Exhibit 247: IBA Radiopharma Solutions - Business segments
Exhibit 248: IBA Radiopharma Solutions - Key news
Exhibit 249: IBA Radiopharma Solutions - Key offerings
Exhibit 250: IBA Radiopharma Solutions - Segment focus
Exhibit 251: SWOT
Exhibit 252: Jubilant Pharma Ltd. - Overview
Exhibit 253: Jubilant Pharma Ltd. - Product / Service
Exhibit 254: Jubilant Pharma Ltd. - Key offerings
Exhibit 255: SWOT
Exhibit 256: Lantheus - Overview
Exhibit 257: Lantheus - Business segments
Exhibit 258: Lantheus - Key offerings
Exhibit 259: Lantheus - Segment focus
Exhibit 260: SWOT
Exhibit 261: NorthStar Medical Radioisotopes - Overview
Exhibit 262: NorthStar Medical Radioisotopes - Product / Service
Exhibit 263: NorthStar Medical Radioisotopes - Key offerings
Exhibit 264: SWOT
Exhibit 265: Novartis AG - Overview
Exhibit 266: Novartis AG - Business segments
Exhibit 267: Novartis AG - Key news
Exhibit 268: Novartis AG - Key offerings
Exhibit 269: Novartis AG - Segment focus
Exhibit 270: SWOT
Exhibit 271: NTP Radioisotopes SOC Ltd. - Overview
Exhibit 272: NTP Radioisotopes SOC Ltd. - Product / Service
Exhibit 273: NTP Radioisotopes SOC Ltd. - Key offerings
Exhibit 274: SWOT
Exhibit 275: PharmaLogic Holdings Corp. - Overview
Exhibit 276: PharmaLogic Holdings Corp. - Product / Service
Exhibit 277: PharmaLogic Holdings Corp. - Key offerings
Exhibit 278: SWOT
Exhibit 279: Siemens Healthineers AG - Overview
Exhibit 280: Siemens Healthineers AG - Business segments
Exhibit 281: Siemens Healthineers AG - Key news
Exhibit 282: Siemens Healthineers AG - Key offerings
Exhibit 283: Siemens Healthineers AG - Segment focus
Exhibit 284: SWOT
Exhibit 285: Sinotau Pharmaceuticals - Overview
Exhibit 286: Sinotau Pharmaceuticals - Product / Service
Exhibit 287: Sinotau Pharmaceuticals - Key offerings
Exhibit 288: SWOT
Exhibit 289: Inclusions checklist
Exhibit 290: Exclusions checklist
Exhibit 291: Currency conversion rates for US$
Exhibit 292: Research methodology
Exhibit 293: Information sources
Exhibit 294: Data validation
Exhibit 295: Validation techniques employed for market sizing
Exhibit 296: Data synthesis
Exhibit 297: 360 degree market analysis
Exhibit 298: List of abbreviations
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Source
Exhibit 6: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 7: Executive Summary - Chart on Market Segmentation by Application
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 22: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Historic Market Size - Data Table on Global Radiopharmaceuticals Market 2020 - 2024 ($ million)
Exhibit 26: Historic Market Size - Source Segment 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - End-user Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - Application Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 31: Five forces analysis - Comparison between 2025 and 2030
Exhibit 32: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 34: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 35: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 37: Chart on Market condition - Five forces 2025 and 2030
Exhibit 38: Chart on Source - Market share 2025-2030 (%)
Exhibit 39: Data Table on Source - Market share 2025-2030 (%)
Exhibit 40: Chart on Comparison by Source
Exhibit 41: Data Table on Comparison by Source
Exhibit 42: Chart on Cyclotrons - Market size and forecast 2025-2030 ($ million)
Exhibit 43: Data Table on Cyclotrons - Market size and forecast 2025-2030 ($ million)
Exhibit 44: Chart on Cyclotrons - Year-over-year growth 2025-2030 (%)
Exhibit 45: Data Table on Cyclotrons - Year-over-year growth 2025-2030 (%)
Exhibit 46: Chart on Nuclear reactors - Market size and forecast 2025-2030 ($ million)
Exhibit 47: Data Table on Nuclear reactors - Market size and forecast 2025-2030 ($ million)
Exhibit 48: Chart on Nuclear reactors - Year-over-year growth 2025-2030 (%)
Exhibit 49: Data Table on Nuclear reactors - Year-over-year growth 2025-2030 (%)
Exhibit 50: Market opportunity by Source ($ million)
Exhibit 51: Data Table on Market opportunity by Source ($ million)
Exhibit 52: Chart on End-user - Market share 2025-2030 (%)
Exhibit 53: Data Table on End-user - Market share 2025-2030 (%)
Exhibit 54: Chart on Comparison by End-user
Exhibit 55: Data Table on Comparison by End-user
Exhibit 56: Chart on Diagnostics - Market size and forecast 2025-2030 ($ million)
Exhibit 57: Data Table on Diagnostics - Market size and forecast 2025-2030 ($ million)
Exhibit 58: Chart on Diagnostics - Year-over-year growth 2025-2030 (%)
Exhibit 59: Data Table on Diagnostics - Year-over-year growth 2025-2030 (%)
Exhibit 60: Chart on Therapeutics - Market size and forecast 2025-2030 ($ million)
Exhibit 61: Data Table on Therapeutics - Market size and forecast 2025-2030 ($ million)
Exhibit 62: Chart on Therapeutics - Year-over-year growth 2025-2030 (%)
Exhibit 63: Data Table on Therapeutics - Year-over-year growth 2025-2030 (%)
Exhibit 64: Market opportunity by End-user ($ million)
Exhibit 65: Data Table on Market opportunity by End-user ($ million)
Exhibit 66: Chart on Application - Market share 2025-2030 (%)
Exhibit 67: Data Table on Application - Market share 2025-2030 (%)
Exhibit 68: Chart on Comparison by Application
Exhibit 69: Data Table on Comparison by Application
Exhibit 70: Chart on Oncology - Market size and forecast 2025-2030 ($ million)
Exhibit 71: Data Table on Oncology - Market size and forecast 2025-2030 ($ million)
Exhibit 72: Chart on Oncology - Year-over-year growth 2025-2030 (%)
Exhibit 73: Data Table on Oncology - Year-over-year growth 2025-2030 (%)
Exhibit 74: Chart on Cardiology - Market size and forecast 2025-2030 ($ million)
Exhibit 75: Data Table on Cardiology - Market size and forecast 2025-2030 ($ million)
Exhibit 76: Chart on Cardiology - Year-over-year growth 2025-2030 (%)
Exhibit 77: Data Table on Cardiology - Year-over-year growth 2025-2030 (%)
Exhibit 78: Chart on Neurology - Market size and forecast 2025-2030 ($ million)
Exhibit 79: Data Table on Neurology - Market size and forecast 2025-2030 ($ million)
Exhibit 80: Chart on Neurology - Year-over-year growth 2025-2030 (%)
Exhibit 81: Data Table on Neurology - Year-over-year growth 2025-2030 (%)
Exhibit 82: Market opportunity by Application ($ million)
Exhibit 83: Data Table on Market opportunity by Application ($ million)
Exhibit 84: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 85: Chart on Market share by geography 2025-2030 (%)
Exhibit 86: Data Table on Market share by geography 2025-2030 (%)
Exhibit 87: Chart on Geographic comparison
Exhibit 88: Data Table on Geographic comparison
Exhibit 89: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 90: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 91: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 92: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 93: Chart on Regional Comparison - North America
Exhibit 94: Data Table on Regional Comparison - North America
Exhibit 95: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 96: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 97: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 98: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 99: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 100: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 101: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 102: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 103: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 104: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 105: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 106: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 107: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 108: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 109: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 110: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 111: Chart on Regional Comparison - Europe
Exhibit 112: Data Table on Regional Comparison - Europe
Exhibit 113: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 114: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 115: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 116: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 117: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 118: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 119: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 120: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 121: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 122: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 123: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 124: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 125: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 126: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 127: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 128: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 129: Chart on Russia - Market size and forecast 2025-2030 ($ million)
Exhibit 130: Data Table on Russia - Market size and forecast 2025-2030 ($ million)
Exhibit 131: Chart on Russia - Year-over-year growth 2025-2030 (%)
Exhibit 132: Data Table on Russia - Year-over-year growth 2025-2030 (%)
Exhibit 133: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 134: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 135: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 136: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 137: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 138: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 139: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 142: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 143: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 144: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 145: Chart on Regional Comparison - Asia
Exhibit 146: Data Table on Regional Comparison - Asia
Exhibit 147: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 148: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 149: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 150: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 151: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 152: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 153: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 154: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 155: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 156: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 157: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 158: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 159: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 160: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 161: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 162: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 163: Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 164: Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 165: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 166: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 167: Chart on Singapore - Market size and forecast 2025-2030 ($ million)
Exhibit 168: Data Table on Singapore - Market size and forecast 2025-2030 ($ million)
Exhibit 169: Chart on Singapore - Year-over-year growth 2025-2030 (%)
Exhibit 170: Data Table on Singapore - Year-over-year growth 2025-2030 (%)
Exhibit 171: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 172: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 173: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 174: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 175: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 176: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 177: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 178: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 179: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 180: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 181: Chart on Australia - Market size and forecast 2025-2030 ($ million)
Exhibit 182: Data Table on Australia - Market size and forecast 2025-2030 ($ million)
Exhibit 183: Chart on Australia - Year-over-year growth 2025-2030 (%)
Exhibit 184: Data Table on Australia - Year-over-year growth 2025-2030 (%)
Exhibit 185: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 186: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 187: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 188: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 189: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 190: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 191: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 192: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 193: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 194: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 195: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 196: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 197: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 198: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 199: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 200: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 201: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 202: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 203: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 204: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 205: Market opportunity by geography ($ million)
Exhibit 206: Data Tables on Market opportunity by geography ($ million)
Exhibit 207: Impact of drivers and challenges in 2025 and 2030
Exhibit 208: Overview on criticality of inputs and factors of differentiation
Exhibit 209: Overview on factors of disruption
Exhibit 210: Impact of key risks on business
Exhibit 211: Companies covered
Exhibit 212: Company ranking index
Exhibit 213: Matrix on companies position and classification
Exhibit 214: Bayer AG - Overview
Exhibit 215: Bayer AG - Business segments
Exhibit 216: Bayer AG - Key news
Exhibit 217: Bayer AG - Key offerings
Exhibit 218: Bayer AG - Segment focus
Exhibit 219: SWOT
Exhibit 220: Bracco S.p.A. - Overview
Exhibit 221: Bracco S.p.A. - Product / Service
Exhibit 222: Bracco S.p.A. - Key offerings
Exhibit 223: SWOT
Exhibit 224: Cardinal Health Inc. - Overview
Exhibit 225: Cardinal Health Inc. - Business segments
Exhibit 226: Cardinal Health Inc. - Key news
Exhibit 227: Cardinal Health Inc. - Key offerings
Exhibit 228: Cardinal Health Inc. - Segment focus
Exhibit 229: SWOT
Exhibit 230: Curium Pharma - Overview
Exhibit 231: Curium Pharma - Product / Service
Exhibit 232: Curium Pharma - Key offerings
Exhibit 233: SWOT
Exhibit 234: Eckert and Ziegler AG - Overview
Exhibit 235: Eckert and Ziegler AG - Business segments
Exhibit 236: Eckert and Ziegler AG - Key news
Exhibit 237: Eckert and Ziegler AG - Key offerings
Exhibit 238: Eckert and Ziegler AG - Segment focus
Exhibit 239: SWOT
Exhibit 240: GE Healthcare Technologies - Overview
Exhibit 241: GE Healthcare Technologies - Business segments
Exhibit 242: GE Healthcare Technologies - Key news
Exhibit 243: GE Healthcare Technologies - Key offerings
Exhibit 244: GE Healthcare Technologies - Segment focus
Exhibit 245: SWOT
Exhibit 246: IBA Radiopharma Solutions - Overview
Exhibit 247: IBA Radiopharma Solutions - Business segments
Exhibit 248: IBA Radiopharma Solutions - Key news
Exhibit 249: IBA Radiopharma Solutions - Key offerings
Exhibit 250: IBA Radiopharma Solutions - Segment focus
Exhibit 251: SWOT
Exhibit 252: Jubilant Pharma Ltd. - Overview
Exhibit 253: Jubilant Pharma Ltd. - Product / Service
Exhibit 254: Jubilant Pharma Ltd. - Key offerings
Exhibit 255: SWOT
Exhibit 256: Lantheus - Overview
Exhibit 257: Lantheus - Business segments
Exhibit 258: Lantheus - Key offerings
Exhibit 259: Lantheus - Segment focus
Exhibit 260: SWOT
Exhibit 261: NorthStar Medical Radioisotopes - Overview
Exhibit 262: NorthStar Medical Radioisotopes - Product / Service
Exhibit 263: NorthStar Medical Radioisotopes - Key offerings
Exhibit 264: SWOT
Exhibit 265: Novartis AG - Overview
Exhibit 266: Novartis AG - Business segments
Exhibit 267: Novartis AG - Key news
Exhibit 268: Novartis AG - Key offerings
Exhibit 269: Novartis AG - Segment focus
Exhibit 270: SWOT
Exhibit 271: NTP Radioisotopes SOC Ltd. - Overview
Exhibit 272: NTP Radioisotopes SOC Ltd. - Product / Service
Exhibit 273: NTP Radioisotopes SOC Ltd. - Key offerings
Exhibit 274: SWOT
Exhibit 275: PharmaLogic Holdings Corp. - Overview
Exhibit 276: PharmaLogic Holdings Corp. - Product / Service
Exhibit 277: PharmaLogic Holdings Corp. - Key offerings
Exhibit 278: SWOT
Exhibit 279: Siemens Healthineers AG - Overview
Exhibit 280: Siemens Healthineers AG - Business segments
Exhibit 281: Siemens Healthineers AG - Key news
Exhibit 282: Siemens Healthineers AG - Key offerings
Exhibit 283: Siemens Healthineers AG - Segment focus
Exhibit 284: SWOT
Exhibit 285: Sinotau Pharmaceuticals - Overview
Exhibit 286: Sinotau Pharmaceuticals - Product / Service
Exhibit 287: Sinotau Pharmaceuticals - Key offerings
Exhibit 288: SWOT
Exhibit 289: Inclusions checklist
Exhibit 290: Exclusions checklist
Exhibit 291: Currency conversion rates for US$
Exhibit 292: Research methodology
Exhibit 293: Information sources
Exhibit 294: Data validation
Exhibit 295: Validation techniques employed for market sizing
Exhibit 296: Data synthesis
Exhibit 297: 360 degree market analysis
Exhibit 298: List of abbreviations
Executive Summary
The following companies are recognized as the key players in the global global radiopharmaceuticals market: Bayer AG, Bracco S.p.A., Cardinal Health Inc., Curium Pharma, Eckert and Ziegler AG, GE Healthcare Technologies, IBA Radiopharma Solutions, Jubilant Pharma Ltd., Lantheus, NorthStar Medical Radioisotopes, Novartis AG, NTP Radioisotopes SOC Ltd., PharmaLogic Holdings Corp., Radiomedix Inc., Siemens Healthineers AG, Sinotau Pharmaceuticals, Telix Pharmaceuticals Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is production of cyclotron-based radiopharmaceuticals."
According to the report, one of the major drivers for this market is the rising incidence of neurological disorders.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Bayer AG
- Bracco S.p.A.
- Cardinal Health Inc.
- Curium Pharma
- Eckert and Ziegler AG
- GE Healthcare Technologies
- IBA Radiopharma Solutions
- Jubilant Pharma Ltd.
- Lantheus
- NorthStar Medical Radioisotopes
- Novartis AG
- NTP Radioisotopes SOC Ltd.
- PharmaLogic Holdings Corp.
- Radiomedix Inc.
- Siemens Healthineers AG
- Sinotau Pharmaceuticals
- Telix Pharmaceuticals Ltd.
